CVS Health Corporation (CVS)
67.94
-0.70 (-1.02%)
At close: Mar 21, 2025, 2:48 PM
-1.02% (1D)
| Bid | 67.92 |
| Market Cap | 85.66B |
| Revenue (ttm) | 373.34B |
| Net Income (ttm) | 4.62B |
| EPS (ttm) | 3.66 |
| PE Ratio (ttm) | 18.56 |
| Forward PE | 9.48 |
| Analyst | Buy |
| Ask | 67.95 |
| Volume | 3,774,445 |
| Avg. Volume (20D) | 11,337,577 |
| Open | 68.46 |
| Previous Close | 68.64 |
| Day's Range | 67.30 - 68.69 |
| 52-Week Range | 43.56 - 80.75 |
| Beta | 0.53 |
About CVS
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment of...
Industry Medical - Healthcare Plans
Sector Healthcare
IPO Date Nov 20, 1996
Employees 219,000
Stock Exchange NYSE
Ticker Symbol CVS
Website https://www.cvshealth.com
Analyst Forecast
According to 17 analyst ratings, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $73, which is an increase of 7.45% from the latest price.
Stock ForecastsNext Earnings Release
CVS Health Corporation is scheduled to release its earnings on Apr 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+1.27%
CVS Health shares are trading higher after Directo...
Unlock content with
Pro Subscription
1 month ago
+4.98%
CVS Health shares are trading higher after multiple firms raised their respective price targets on the stock and Leerink Partners upgraded its rating from Market Perform to Outperform. Additionally, the company may be moving on continued strength following a reported Q4 revenue and earnings beat on Wednesday.
